| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 12/24/2008 | WO2008157776A2 Modified diphtheria toxins |
| 12/24/2008 | WO2008157659A1 Emulsion vaccine compositions comprising antigen and adjuvant in the aqueous phase |
| 12/24/2008 | WO2008157590A1 Modified polysaccharides for conjugate vaccines |
| 12/24/2008 | WO2008157530A2 Vaccine design methodology |
| 12/24/2008 | WO2008157419A2 Immunogenic peptides of influenza virus |
| 12/24/2008 | WO2008157409A1 Lyophilized immunoglobulin formulations and methods of preparation |
| 12/24/2008 | WO2008157282A1 Biological markers predictive of rheumatoid arthritis response to b-cell antagonists |
| 12/24/2008 | WO2008157263A2 Methods of delivery of molecules to cells using a ricin subunit and compositions relating to same |
| 12/24/2008 | WO2008157236A1 Vaccines containing canine parvovirus genetic variants |
| 12/24/2008 | WO2008157203A2 Methods of protecting animals from avian influenza infection |
| 12/24/2008 | WO2008157136A1 Chimeric sle/dengue type 4 antigenic viruses |
| 12/24/2008 | WO2008156853A2 Inhibition of filovirus entry into cells and uses thereof |
| 12/24/2008 | WO2008156829A2 Promoterless cassettes for expression of alphavirus structural proteins |
| 12/24/2008 | WO2008156778A2 Influenza m2 protein mutant viruses as live influenza attenuated vaccines |
| 12/24/2008 | WO2008156763A2 Human neutralizing monoclonal antibodies to h5n1 influenza a virus |
| 12/24/2008 | WO2008156729A2 Vaccines against chlamydia infection |
| 12/24/2008 | WO2008156713A2 Anti-cd20 therapeutic compositions and methods |
| 12/24/2008 | WO2008156712A1 Antibodies to human programmed death receptor pd-1 |
| 12/24/2008 | WO2008156681A2 Adenoviral vectors for influenza virus production |
| 12/24/2008 | WO2008156642A1 Non-immunoglobulin antigen binding scaffolds for inhibiting angiogenesis and tumor growth |
| 12/24/2008 | WO2008156629A2 Methods and agents for inhibiting tumor growth by targeting the ssdna replication intermediate of tumor stem cells |
| 12/24/2008 | WO2008156622A1 Humanized antibodies to amyloid beta |
| 12/24/2008 | WO2008156621A1 Monoclonal anti beta amyloid antibody |
| 12/24/2008 | WO2008156494A1 Use of high-dose oxazaphosphorine drugs in combination with monoclonal antibodies for treating immune disorders |
| 12/24/2008 | WO2008156418A1 A method for screening or diagnosis of postpolio syndrome and fibromyalgia |
| 12/24/2008 | WO2008156153A1 Preventive/remedy for cancer |
| 12/24/2008 | WO2008156124A1 Method for separation of immunoglobulin monomer |
| 12/24/2008 | WO2008156069A1 Screening method for antibody and antibody obtained by the method |
| 12/24/2008 | WO2008155918A1 REGULATION OF HIF-1 BY MT1-MMP, iFIH AND FIH-1 |
| 12/24/2008 | WO2008155387A2 Anti-igf antibodies that bind to igf-1 and igf-2 but not to insulin |
| 12/24/2008 | WO2008155316A1 Immunogenic compositions associated with sars corona virus spike protein |
| 12/24/2008 | WO2008155120A2 Methods and compositions for treating mucositis |
| 12/24/2008 | WO2008154927A1 Novel methods for treating egfr-associated tumors |
| 12/24/2008 | WO2008154868A1 Capsid proteins and uses therefore |
| 12/24/2008 | WO2008154867A1 Material with immunogenicity |
| 12/24/2008 | WO2008154813A1 Monoclonal antibodies binding to avian influenza virus subtype h5 haemagglutinin and uses thereof |
| 12/24/2008 | WO2008137500A3 Immunosuppression with antibody against itm2a |
| 12/24/2008 | WO2008134659A3 Antagonists to il-17a, il-17f, and il-23p19 and methods of use |
| 12/24/2008 | WO2008130704A3 PDGFRβ-SPECIFIC INHIBITORS |
| 12/24/2008 | WO2008130433A3 Methods for providing prophylactic surface treatment for fluid processing systems and components thereof |
| 12/24/2008 | WO2008127290A9 Alginate and alginate lyase compositions and methods of use |
| 12/24/2008 | WO2008124698A3 Methods of use of gamma inhibitor compounds for the attenuation of pain |
| 12/24/2008 | WO2008119358A3 Surface-located streptococcus pneumoniae polypeptides for use in vaccine compositions |
| 12/24/2008 | WO2008113970A3 Peptides |
| 12/24/2008 | WO2008113011A3 Virus like particle purification |
| 12/24/2008 | WO2008105959A3 Cerebrospinal fluid purification system |
| 12/24/2008 | WO2008101179A3 Use of sucrose to suppress mannitol-induced protein aggregation |
| 12/24/2008 | WO2008097866A3 Vaccines based on targeting antigen to dcir expressed an antigen-presenting cells |
| 12/24/2008 | WO2008084411A3 Modified saccharides |
| 12/24/2008 | WO2008084410A3 Human cytomegalovirus neutralising antibodies and use thereof |
| 12/24/2008 | WO2008079732A3 Multivalent pneumococcal polysaccharide-protein conjugate composition |
| 12/24/2008 | WO2008073615A9 N-glycosylation mutant of melanoma differentiation associated gene-7 |
| 12/24/2008 | WO2008066774A3 INTERFERON-β PRODUCTION MODULATING LISTERIA STRAINS AND METHODS FOR USING SAME |
| 12/24/2008 | WO2008060617A3 Therapeutic uses of tim-3 modulators |
| 12/24/2008 | WO2008057696A3 Compositions of pattern recognition receptor-ligand: lipid complexes and methods of use thereof |
| 12/24/2008 | WO2008057529A3 Peptide-based vaccine compositions to endogenous cholesteryl ester transfer protein (cetp) |
| 12/24/2008 | WO2008052165A3 Method for treating pathological pulmonary conditions and bleomycin associated pulmonary fibrosis |
| 12/24/2008 | WO2007130470A3 Cytomegalovirus peptides and methods of use thereof |
| 12/24/2008 | WO2007120461A3 Compositions and methods for controlling a honey bee parasitic mite |
| 12/24/2008 | WO2007103162A3 Structure based drug design of steroidogenesis inhibitors |
| 12/24/2008 | WO2007076084A3 Allergy inhibitor compositions and kits and methods of using the same |
| 12/24/2008 | WO2006127798A3 Anti-adhesin based passive immunoprophylactic |
| 12/24/2008 | WO2006088597A3 A plasmodium vivax hybrid circumsporozoite protein and vaccine |
| 12/24/2008 | WO2006088508A3 Cupredoxin derived transport agents and methods of use thereof |
| 12/24/2008 | WO2006078680A3 Polypeptides for inducing a protective immune response against staphylococcus aureus |
| 12/24/2008 | WO2006072152A3 Suppressor of disease-associated autoreactive b iymphocytes |
| 12/24/2008 | EP2006681A1 Rheumatoid arthritis test method and treating method |
| 12/24/2008 | EP2006395A1 Molecular differences between species of the M. tuberculosis complex |
| 12/24/2008 | EP2006384A1 Preprocalcitonin-derived antigen epitopes |
| 12/24/2008 | EP2006381A1 Method for control of blood kinetics of antibody |
| 12/24/2008 | EP2006380A1 Agonistic antibody directed against human thrombopoietin receptor |
| 12/24/2008 | EP2006379A1 High functional bispecific antibody |
| 12/24/2008 | EP2006302A2 Protein complex and process for production thereof |
| 12/24/2008 | EP2006301A1 Peptide-based immunization therapy for treatment of atherosclerosis |
| 12/24/2008 | EP2006300A2 Characterization of a calcium channel family |
| 12/24/2008 | EP2005996A2 Immunotherapeutic combination for the treatment of tumors |
| 12/24/2008 | EP2005165A2 Separation of conjugated and unconjugated components |
| 12/24/2008 | EP2004844A2 Coadministration of alpha-fetoprotein and a disease modifying anti-rheumatic drug for treating inflammatory arthritic disease |
| 12/24/2008 | EP2004841A1 Compositions and methods for the analysis and treatment of aids wasting syndrome and immune cell dysfunction |
| 12/24/2008 | EP2004833A1 Anti-inflammatory proteins and improved vaccines |
| 12/24/2008 | EP2004802A1 Live attenuated salmonella vaccine |
| 12/24/2008 | EP2004694A2 Methods for preventing and treating amyloidogenic diseases |
| 12/24/2008 | EP2004693A2 Compositions and methods of use for antibodies of c-met |
| 12/24/2008 | EP2004692A1 Treatment of multiple sclerosis and/or rheumatoid arthritis |
| 12/24/2008 | EP2004691A1 Antibody specific for human il-4 for the treament of cancer |
| 12/24/2008 | EP2004690A2 Amino acid sequences directed against il-6 and polypeptides comprising the same for the treatment of diseases and disorders associated with il-6-mediated signalling |
| 12/24/2008 | EP2004689A2 Antibody purification |
| 12/24/2008 | EP2004688A1 Improved protofibril selective antibodies and the use thereof |
| 12/24/2008 | EP2004686A1 Recombinant polyclonal antibody for treatment of respiratory syncytial virus infections |
| 12/24/2008 | EP2004666A2 Ras mutation and compositions and methods related thereto |
| 12/24/2008 | EP2004233A1 Concentrate of chikungunya-specific immunoglobulins as medicine |
| 12/24/2008 | EP2004232A2 Method and composition for treatment of renal disease with antibodies and their equivalents |
| 12/24/2008 | EP2004231A2 Conjugates of an anti-tnf-alpha antibody |
| 12/24/2008 | EP2004229A2 Concentrate of immunoglobulins and f(ab)'2 and/or fab fragments specific of an arbovirus as medicine |
| 12/24/2008 | EP2004228A1 Methods for damaging cells using effector functions of anti-epha4 antibodies |
| 12/24/2008 | EP2004227A2 Compositions and methods for immunisation using cd1d ligands |
| 12/24/2008 | EP2004226A1 Storage of influenza vaccines without refrigeration |
| 12/24/2008 | EP2004225A2 Regimens for immunisation with meningococcal conjugates |
| 12/24/2008 | EP2004224A2 Conjugate vaccines |
| 12/24/2008 | EP2004223A1 Type 5 and type 8 capsular polysaccharides of superproducing staphylococcus aureus strains |